Ivantis Secures $27,000,000 Series B Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9f60c94a-68a9-4e31-9a18-67b09bd667da&Preview=1 - Date
2/1/2013 - Company Name
Ivantis - Mailing Address
13766 Alton Parkway Irvine, CA 92618 - Company Description
The company provides medical devices for the treatment of glaucoma. - Website
http://www.ivantisinc.com - Transaction Type
Venture Equity - Transaction Amount
$27,000,000 - Transaction Round
Series B - Proceeds Purposes
These funds will be used to support four randomized, prospective, controlled multi-center trials at various stages around the world, including the ongoing United States trial. - M&A Terms
- Venture Investor
Ascension Health Ventures - Venture Investor
New Enterprise Associates - Venture Investor
Delphi Ventures - Venture Investor
Undisclosed
